Contact us
Menu
Contact us

Feldan News

on Apr 14,2021

Read more on pages 54 to 57: BIOTECanada Insights sping 2021 …

Read Story

on Apr 7,2021

Congratulations to the team at NIH Common Fund’s Somatic Cell Genome Editing (SCGE) program for publishing their work in the journal Nature. Feldan is honoured to be part of this initiative alongside its long-standing collaborator, Dr. Paul McCray of the University of Iowa. https://www.nature.com/articles/s41586-021-03191-1 About the collaboration between Dr. McCray and Feldan Therapeutics: The lungs, …

Read Story

on Feb 9,2021

Québec, Canada, February 9, 2021 – Feldan Therapeutics, a biotechnology company that develops therapeutics based on the intracellular delivery of proteins and peptides, announces the appointment of Dr. David J …

Read Story

on Jan 14,2021

Quebec City, Canada, January 14, 2021 – Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on the intracellular delivery of proteins and peptides, announces the creation …

Read Story

on Jun 16,2020

Quebec City, Canada, June 16, 2020, Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on its intracellular delivery technology, today announced the appointment of Dr. Robert …

Read Story

on Oct 28,2019

Dr. Paul McCray (University of Iowa) and Feldan Therapeutics enable protein and CRISPR nuclease delivery to cultured human well-differentiated airway epithelial cells and in vivo using the Feldan Shuttle technology …

Read Story

on Jun 14,2019

On June 13th 2019, Anges Québec celebrated its 10th anniversary as part of the annual Rendez-vous 2019, the event that brings together angel investors, portfolio companies, venture capital ecosystem players …

Read Story

on Jun 4,2019

Philadelphia, June 4th, 2019 – CQDM is pleased to announce that following their recent enrollment in the consortium, Amgen and Takeda will be joining the syndicate of pharma companies to …

Read Story

on Feb 8,2019

Feldan Therapeutics is proud to unveil its new corporate identity! This new visual highlights the company's commitment to the therapeutic development of the Feldan Shuttle technology, an innovation developed in-house …

Read Story

on Dec 5,2018

Congratulations to Francois-Thomas Michaud for winning the “Visionary Entrepreneur of the Year” Award given by the CCIQ Chambre de commerce et d’industrie de Québec. Congratulations to Feldan Therapeutics’s team for its contribution to the success …

Read Story